ArticleScientific reports2025
Novel dual action chimera doxorubizen demonstrates superior efficacy to doxorubicin in acute leukemia.
Dipak Walunj et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it